General MedicationsIV (INFUSION)Standard
VECTIBIX
PANITUMUMAB
Standard Dose
10ML/200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary
Approval overview VECTIBIX is listed in Drugs@FDA under application 125147 (BLA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient PANITUMUMAB Form and strength INJECTABLE; IV (INFUSION) - 10ML/200MG Sponsor AMGEN Submission history Latest submission status date: 2025-01-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview VECTIBIX is listed in Drugs@FDA under application 125147 (BLA). Review priority: PRIORITY Marketing status: Prescription Active ingredient PANITUMUMAB Form and strength INJECTABLE; IV (INFUSION) - 10ML/200MG Sponsor AMGEN Submission history Latest submission status date: 2025-01-16 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.